Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1033 to 1082 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1033\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosinase precursor (ec 1.14.18.1) (monophenol monooxygenase) (tumor rejection antigen ab) (sk29-ab) (lb24-ab). [source:swissprot;acc:p14679]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.183\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.406\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03161\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1034\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
steroid hormone receptor err2 (estrogen-related receptor, beta) (err-beta) (estrogen receptor-like 2) (err beta-2). [source:swissprot;acc:o95718]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
186.551\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
180.837\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0316\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1035\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atrophin-1 interacting protein 1; activin receptor interacting protein 1; likely ortholog of mouse activin receptor interacting protein 1; atrophin-1 interacting protein a; membrane associated guanylate kinase 2; activin receptor interacting p. [source:refseq;acc:nm\_012301]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.682\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03157\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1036\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
coatomer beta subunit (beta-coat protein) (beta-cop). [source:swissprot;acc:p53618]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
171.341\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
176.746\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03155\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1037\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
thioredoxin-like; pkc-interacting cousin of thioredoxin. [source:refseq;acc:nm\_006541]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
228.412\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
235.609\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03151\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1038\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (ec 2.3.1.51) (1- agp acyltransferase 1) (1-agpat 1) (lysophosphatidic acid acyltransferase-alpha) (lpaat-alpha) (1-acylglycerol-3-phosphate o- acyltransferase 1) (g15 protein). [source:swissprot;acc:q99943]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
186.741\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
181.041\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03148\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1039\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dihydrolipoamide dehydrogenase, mitochondrial precursor (ec 1.8.1.4) (glycine cleavage system l protein). [source:swissprot;acc:p09622]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
207.719\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.236\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03137\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1040\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
t-complex protein 1, epsilon subunit (tcp-1-epsilon) (cct-epsilon). [source:swissprot;acc:p48643]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
163.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
168.359\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03136\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1041\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein l (hnrnp l). [source:swissprot;acc:p14866]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
186.774\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
181.099\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03134\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1042\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
estrogen-related receptor gamma (estrogen receptor related protein 3) (err gamma-2). [source:swissprot;acc:o75454]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
186.799\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
181.127\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03132\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1043\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (ec 2.3.1.51) (1- agp acyltransferase 3) (1-agpat 3) (lysophosphatidic acid acyltransferase-gamma) (lpaat-gamma) (1-acylglycerol-3-phosphate o- acyltransferase 3). [source:swissprot;acc:q9nrz7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
187.834\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
182.137\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03128\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1044\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
t-complex associated-testis-expressed 1-like (protein 91/23). [source:swissprot;acc:p51808]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
173.475\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
178.889\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03121\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1045\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fip1-like 1; rearranged in hypereosinophilia. [source:refseq;acc:nm\_030917]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
115.817\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
119.432\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1046\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
double-strand break repair protein mre11a (mre11 homolog 1). [source:swissprot;acc:p49959]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
173.475\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
178.889\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1047\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
steroid hormone receptor err1 (estrogen-related receptor, alpha) (err-alpha) (estrogen receptor-like 1). [source:swissprot;acc:p11474]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
187.022\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
181.391\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03104\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1048\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase delta (ec 2.3.1.51) (1- agp acyltransferase 4) (1-agpat 4) (lysophosphatidic acid acyltransferase-delta) (lpaat-delta) (1-acylglycerol-3-phosphate o- acyltransferase 4). [source:swissprot;acc:q9nrz5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
187.96\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
182.308\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.031\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1049\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenine phosphoribosyltransferase (ec 2.4.2.7) (aprt). [source:swissprot;acc:p07741]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
211.449\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
217.998\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03097\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1050\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
estradiol 17 beta-dehydrogenase 1 (ec 1.1.1.62) (17-beta-hsd 1) (placental 17-beta-hydroxysteroid dehydrogenase) (20 alpha- hydroxysteroid dehydrogenase) (20-alpha-hsd) (e2dh). [source:swissprot;acc:p14061]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1051\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
17 beta-hydroxysteroid dehydrogenase. [source:sptrembl;acc:q13034]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1052\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
retinol dehydrogenase 8 (all-trans); photoreceptor outer segment all-trans retinol dehydrogenase. [source:refseq;acc:nm\_015725]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1053\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit alpha type 5 (ec 3.4.25.1) (proteasome zeta chain) (macropain zeta chain) (multicatalytic endopeptidase complex zeta chain). [source:swissprot;acc:p28066]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
207.04\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
200.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03087\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1054\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l21. [source:swissprot;acc:p46778]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
223.958\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.263\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03082\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1055\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hcv ns3-transactivated protein 1. [source:refseq;acc:nm\_019048]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
219.01\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
212.468\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03079\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1056\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase catalytic subunit a, ubiquitous isoform (ec 3.6.3.14) (v-atpase a subunit 1) (vacuolar proton pump alpha subunit 1) (v-atpase 69 kda subunit 1) (isoform va68). [source:swissprot;acc:p38606]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1057\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
asparagine synthetase [glutamine-hydrolyzing] (ec 6.3.5.4) (glutamine- dependent asparagine synthetase) (ts11 cell cycle control protein). [source:swissprot;acc:p08243]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1058\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ataxin 2 related protein isoform a; ataxin-2 domain protein. [source:refseq;acc:nm\_007245]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
228.105\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
221.293\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03078\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1059\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ataxin 2; olivopontocerebellar ataxia 2, autosomal dominant. [source:refseq;acc:nm\_002973]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1060\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nemo-like kinase; likely ortholog of mouse nemo like kinase. [source:refseq;acc:nm\_016231]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
218.162\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
211.648\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1061\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
elks protein. [source:refseq;acc:nm\_015064]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1062\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 174 (aw-1). [source:swissprot;acc:q15697]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
269.963\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
278.239\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03066\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1063\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger imprinted 2. [source:swissprot;acc:q9nzv7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
269.96\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
278.232\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03064\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1064\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 24 (zinc finger protein 191) (zinc finger protein kox17) (retinoic acid suppression protein a) (rsg-a). [source:swissprot;acc:p17028]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
269.955\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
278.221\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03062\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1065\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 305. [source:swissprot;acc:o43309]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
269.954\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
278.219\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1066\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 18 (zinc finger protein kox11) (fragment). [source:swissprot;acc:p17022]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
269.956\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
278.223\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1067\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 215 (bwscr2 associated zinc-finger protein 2) (baz 2). [source:swissprot;acc:q9ul58]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1068\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 274 (zinc finger protein sp2114) (zinc finger protein hfb101) (zinc finger protein zfp2) (zf2). [source:swissprot;acc:q96gc6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
269.953\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
278.215\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03061\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1069\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 232. [source:swissprot;acc:q9uny5]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
269.954\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
278.218\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1070\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 99. [source:refseq;acc:nm\_032164]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1071\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase i 16 kda polypeptide (ec 2.7.7.6) (rpa16). [source:swissprot;acc:q9y2s0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
231.277\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
238.356\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1072\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 213 (putative transcription factor cr53). [source:swissprot;acc:o14771]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
269.954\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
278.217\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1073\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ww domain binding protein 2 (wbp-2). [source:swissprot;acc:q969t9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.901\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.485\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03048\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1074\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
coatomer beta' subunit (beta'-coat protein) (beta'-cop) (p102). [source:swissprot;acc:p35606]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
174.387\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
179.697\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03045\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1075\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
coatomer gamma subunit (gamma-coat protein) (gamma-cop). [source:swissprot;acc:q9y678]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1076\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
coatomer zeta-1 subunit (zeta-1 coat protein) (zeta-1 cop) (cgi-120) (hspc181). [source:swissprot;acc:q9y3c3]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1077\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
coatomer delta subunit (delta-coat protein) (delta-cop) (archain). [source:swissprot;acc:p48444]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1078\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peptidyl-prolyl cis-trans isomerase e (ec 5.2.1.8) (ppiase e) (rotamase e) (cyclophilin e) (cyclophilin 33). [source:swissprot;acc:q9unp9]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1079\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
coatomer zeta-2 subunit (zeta-2 coat protein) (zeta-2 cop). [source:swissprot;acc:q9p299]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1080\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 444; endothelial zinc finger protein 2. [source:refseq;acc:nm\_018337]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
269.896\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
278.093\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03037\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1081\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s30. [source:swissprot;acc:q05472]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
223.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.875\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03027\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1082\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phafin 2; ph and fyve domain-containing protein 2. [source:refseq;acc:nm\_024613]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
220.118\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.685\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03011\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/